Squarepoint’s Ocugen OCGN Stock Holding History

Squarepoint’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-79,700	Closed	-$64.2K	–	5169
2024 Q4	$64.2K	Buy	+79,700	New	+$73K	﹤0.01%	4801

Other funds holding OCGN

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Squarepoint's OCGN Position: Q1 2026 in Review

Squarepoint increased its Ocugen (OCGN) stake by 99% in Q1 2026, buying an estimated $373K and bringing the position to 434,009 shares worth $786K. The position accounts for ﹤0.01% of the portfolio, ranked #2976.

Squarepoint first reported a position in OCGN in Q1 2020 and has held it in 15 quarters since. The position peaked at $954K in Q2 2021. 137 funds tracked by Wall St. Rank hold OCGN as of Q1 2026.

Squarepoint held 434,009 shares of Ocugen worth $786K as of Q1 2026.
Squarepoint bought 215,617 Ocugen shares in Q1 2026, an estimated $373K.
Ocugen made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2976 holding.
Squarepoint first reported a position in Ocugen in Q1 2020 and has held it in 15 quarters since.
Squarepoint's Ocugen position peaked at $954K in Q2 2021.
137 funds tracked by Wall St. Rank held Ocugen as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.